GlaxoSmithKline China health care unit 'part of US probe'

A US anti-bribery probe into GSK touched on the firm's Chinese consumer health care business in 2012, internal documents show, suggesting the drugmaker's compliance problems in China could go wider than previously revealed.

via Business feed http://ift.tt/1p41G4v